Phase I Study of adjuvant chemotherapy for the patients resected pathological stage IA(T1>2cm) Non Small Cell Lung Cancer (SLCG0701)
Not Applicable
- Conditions
- on Small Cell Lung Cancer
- Registration Number
- JPRN-UMIN000006967
- Lead Sponsor
- Setouchi Lung Cancer Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
1. sever infection, uncontrolled Diabetes Mellitus, and hypertension 2. unstable angina or Myocardial Infarction within 6 months 3. apparent interstitial pneumonitis at chest rentogenogram 4. systemic steroid therapy required 5. uncontrolled cancer 6. Pregnant or expecting woman 7. serious psychiatric illness 8. usaige of other fluorinated pyrimidine drugs 9. Concomitant therapy with flucytocine, phenytoin or Warfarin Potassium
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method